Cooper Companies reported record second quarter revenue of $1.082 billion with non-GAAP diluted EPS of $1.21, up 26% from the prior year, driven by solid execution and new product launches. The company reached settlement agreements to resolve substantially all claims related to CooperSurgical's fertility media recall, clearing a major overhang.